A drug combo of dapagliflozin and exenatide continues to stay effective at controlling the progression of type 2 diabetes, without loss of effect, after two years of continual use, according to a study recently published in Diabetes Care. In a multi-center double-blind, phase 3, randomized controlled trial, a total of 695 adults whose type 2...
The Endocrine Society has been leading the charge for adopting innovative diabetes care models since 2018. However, the specter of the COVID-19 pandemic has forced the entire healthcare industry to rethink how patients are treated, resulting in an unprecedented wave of innovation that could revolutionize how care is delivered. In early March, Robert A. Gabbay,...
Among the environmental disruptors that contribute to the development of diabetes, air pollution is gaining the spotlight. Airborne microscopic endocrine disruptors not only get in the lungs, but also find their way into the bloodstream where they can cause organ damage, specifically to the pancreas. Health professionals uniformly endorse wearing a mask to lower...
On the cusp of the 100-year anniversary of the discovery of insulin, Endocrine Reviews takes a look at how this therapy has evolved throughout the last century as well as how it has informed treatment options with a comprehensive guide that will prove to be an invaluable resource for another hundred years. Endocrinologists worldwide...
The COVID-19 pandemic has jumpstarted innovation in healthcare delivery and allowed for real-world testing of diabetes care models in unprecedented ways, according to a manuscript published in The Journal of Clinical Endocrinology & Metabolism. For diabetes, which affects half a billion people worldwide, innovation has long been overdue. Currently, less than 50% of people with...
First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources This past summer, Glytec published the first proof-of-concept study that combines FDA-cleared remote insulin titration software and data from continuous glucose monitoring (CGM) systems. Results of the study, presented at the American Diabetes Association’s...
Dexcom last month announced it has signed a five-year collaboration agreement with the University of Virginia to advance its research and development efforts on continuous glucose monitoring-based solutions. The research partnership will center on advancing Dexcom’s automated insulin delivery technology and exploring the use of continuous glucose monitoring tools outside the type 1 diabetes market,...
A new tool for anyone in the United States struggling to access life-sustaining insulin launched today at GetInsulin.org. Created by global diabetes nonprofit organization Beyond Type 1, GetInsulin.org connects people with diabetes who take insulin to assistance programs and low-cost solutions that match their unique situation. Insulin is a life-essential medicine for over seven million people with...
The Endocrine Society has been leading the charge for adopting innovative diabetes care models since 2018. However, the specter of the COVID-19 pandemic has forced the entire healthcare industry to rethink how patients are treated, resulting in an unprecedented wave of innovation that could revolutionize how care is delivered. In early March, Robert A. Gabbay,...
On the cusp of the 100-year anniversary of the discovery of insulin, Endocrine Reviews takes a look at how this therapy has evolved throughout the last century as well as how it has informed treatment options with a comprehensive guide that will prove to be an invaluable resource for another hundred years. Endocrinologists worldwide...
